av/tubize-fin--big.svg

EURONEXT:TUB

Financière de Tubize SA

  • Stock

129.80

+2.85%

3.60

EUR last updated 08/08 02:05:20

Last Close

126.20

02/05 08:29

Market Cap

4.85B

Beta: 0.46

Volume Today

4.64K

Avg: 6.98K

PE Ratio

19.09

PFCF: 19.09

Dividend Yield

1.15%

Payout:19.16%

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Financière de Tubize SA, through its interest in UCB, operates as a biopharmaceutical company worldwide. It discovers and develops medicines and solutions in the therapeutic areas of neurology and immunology diseases. The company's products include Cimzia for treating ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, pla...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1123452018-03-312019-03-312020-06-292021-12-312024-03-16

    Revenue (Estimate*)

    2K4K6K8K2018-03-312019-03-312020-06-292021-12-312024-03-16

    *Estimate based on analyst consensus